The "Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
Global human insulin market is expected to reach $53.16 billion by 2026, representing a 2019-2026 CAGR of 7.47%.
Highlighted with 83 tables and 87 figures, this 161-page report Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter's Fiver Forces
Key Topics Covered:
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Fiver Forces Analysis
3 Segmentation of Global Market by Product Type
3.1 Market Overview by Product Type
3.2 Human Insulin Drugs
3.3 Human Insulin Delivery Devices
4 Segmentation of Global Human Insulin Drugs Market by Drug Product
4.1 Market Overview by Drug Product
4.2 Modern Human Insulin
4.2.1 Modern Human Insulin by Type
4.2.2 Modern Human Insulin by Brand
4.3 Traditional Human Insulin
4.3.1 Traditional Human Insulin by Type
4.3.2 Traditional Human Insulin by Brand
5 Segmentation of Global Human Insulin Delivery Devices Market by Device Product
5.1 Market Overview by Product
5.2 Syringes
5.3 Pens
5.4 Pumps
5.5 Other Devices
6 Segmentation of Global Market by Application
6.1 Market Overview by Application
6.2 Type 1 Diabetes
6.3 Type 2 Diabetes
6.4 Gestational Diabetes and Prediabetes
7 Segmentation of Global Market by Distribution Channel
7.1 Market Overview by Distribution Channel
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
8 Segmentation of Global Market by Region
8.1 Geographic Market Overview 2019-2026
8.2 North America Market 2019-2026 by Country
8.2.1 Overview of North America Market
8.2.2 U.S. Market
8.2.3 Canadian Market
8.3 European Market 2019-2026 by Country
8.3.1 Overview of European Market
8.3.2 Germany
8.3.3 UK
8.3.4 France
8.3.5 Spain
8.3.6 Italy
8.3.7 Rest of European Market
8.4 Asia-Pacific Market 2019-2026 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 Japan
8.4.3 China
8.4.4 Australia
8.4.5 India
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 Latin America Market 2019-2026 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Mexico
8.5.4 Rest of Latin America Market
8.6 Rest of World Market 2019-2026 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets
9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles:
- Astra Zeneca PLC
- Biocon
- Eli Lilly
- Exir
- Julphar
- Novo Nordisk AS
- Pfizer
- Sanofi Aventis
- Sedico
- Wockhardt
10 Investing in Global Market: Risk Assessment and Management
10.1 Risk Evaluation of Global Market
10.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/a0i9e2
View source version on businesswire.com: https://www.businesswire.com/news/home/20200124005174/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
